Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells

Binder, 2002, Innate and acquired immunity in atherogenesis, Nat. Med., 8, 1218, 10.1038/nm1102-1218 Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N. Engl. J. Med., 352, 1685, 10.1056/NEJMra043430 Davenport, 2003, The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice, Am. J. Pathol., 163, 1117, 10.1016/S0002-9440(10)63471-2 Pinderski, 2002, Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes, Circ. Res., 90, 1064, 10.1161/01.RES.0000018941.10726.FA Potteaux, 2004, Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice, Arterioscler. Thromb. Vasc. Biol., 24, 1474, 10.1161/01.ATV.0000134378.86443.cd Gojova, 2003, Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice, Blood, 102, 4052, 10.1182/blood-2003-05-1729 Mallat, 2001, Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice, Circ. Res., 89, 930, 10.1161/hh2201.099415 Mallat, 2007, Regulatory T-cell immunity in atherosclerosis, Trends Cardiovasc. Med., 17, 113, 10.1016/j.tcm.2007.03.001 Ait-Oufella, 2006, Natural Tregs control the development of atherosclerosis in mice, Nat. Med., 12, 178, 10.1038/nm1343 Mor, 2007, Role of naturally occurring CD4+CD25+ Tregs in experimental atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 27, 893, 10.1161/01.ATV.0000259365.31469.89 Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ Tregs, Nat. Immunol., 4, 330, 10.1038/ni904 Hori, 2003, Control of regulatory T cell development by the transcription factor Foxp3, Science (New York, NY), 299, 1057, 10.1126/science.1079490 Mallat, 2003, Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice, Circulation, 108, 1232, 10.1161/01.CIR.0000089083.61317.A1 Chang, 2006, Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells, Biol. Pharm. Bull., 29, 1597, 10.1248/bpb.29.1597 Laster, 1975, Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056), Cancer Chemother. Rep., 59, 951 Milazzo, 2007, Laetrile for cancer: a systematic review of the clinical evidence, Support. Care Cancer, 15, 583, 10.1007/s00520-006-0168-9 Heikkila, 1980, The prevention of alloxan-induced diabetes by amygdalin, Life Sci., 27, 659, 10.1016/0024-3205(80)90006-5 Baroni, 2005, Immunomodulatory effects of a set of amygdalin analogues on human keratinocyte cells, Exp. Dermatol., 14, 854, 10.1111/j.1600-0625.2005.00368.x Hwang, 2008, Inhibitory effect of amygdalin on lipopolysaccharide-inducible TNF-alpha and IL-1beta mRNA expression and carrageenan-induced rat arthritis, J. Microbiol. Biotechnol., 18, 1641 Nabel, 1988, Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test, Circulation, 77, 43, 10.1161/01.CIR.77.1.43 Antony, 1994, Coronary artery constriction caused by the cold pressor test in human hypertension, Hypertension, 24, 212, 10.1161/01.HYP.24.2.212 Antony, 1996, Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients, Circulation, 94, 3115, 10.1161/01.CIR.94.12.3115 Plump, 1992, Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells, Cell, 71, 343, 10.1016/0092-8674(92)90362-G George, 2000, Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice, Circulation, 102, 1822, 10.1161/01.CIR.102.15.1822 George, 2001, Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice, J. Am. Coll. Cardiol., 38, 900, 10.1016/S0735-1097(01)01440-1 Cobbold, 2004, Induction of Foxp3+ Tregs in the periphery of T cell receptor transgenic mice tolerized to transplants, J. Immunol., 172, 6003, 10.4049/jimmunol.172.10.6003 Gondek, 2005, Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism, J. Immunol., 174, 1783, 10.4049/jimmunol.174.4.1783 Zhou, 2000, Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice, Circulation, 102, 2919, 10.1161/01.CIR.102.24.2919 Steffens, 2006, Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice, Circulation, 114, 1977, 10.1161/CIRCULATIONAHA.106.627430 van Puijvelde, 2006, Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis, Circulation, 114, 1968, 10.1161/CIRCULATIONAHA.106.615609 Belghith, 2003, TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes, Nat. Med., 9, 1202, 10.1038/nm924 Akbari, 2001, Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen, Nat. Immunol., 2, 725, 10.1038/90667 Ochs, 2005, FOXP3 acts as a rheostat of the immune response, Immunol. Rev., 203, 156, 10.1111/j.0105-2896.2005.00231.x Mor, 2006, Altered status of CD4(+)CD25(+) Tregs in patients with acute coronary syndromes, Eur. Heart J., 27, 2530, 10.1093/eurheartj/ehl222 Brunkow, 2001, Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse, Nat. Genet., 27, 68, 10.1038/83784